Smith & Nephew plc (SNN) Stock

Healthcare · Medical Devices · Member of Other US Stocks

Smith & Nephew plc (SNN) closed at USD 27.88 on 2026-10-14, a change of -21.6 % over the past year, with a market capitalization of USD 12.17B.

Smith & Nephew plc recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Smith & Nephew plc key figures

Previous close

USD 27.88 (2026-10-14)

1-year change

-21.6 %

Market cap

USD 12.17B

Enterprise value

USD 64.93B

P/E ratio (trailing)

19.01

P/E ratio (forward)

12.08

EPS (trailing)

1.53

EPS (forward)

2.41

PEG ratio

1.07

Price to book

11.95

Revenue growth

4.6 %

Earnings growth

5.7 %

Dividend per share (trailing)

0.40

Short ratio

2.63

Employees

17,000

Analyst consensus (third-party)

hold

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Smith & Nephew plc

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. The company also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, it provides arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, the company offers advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Smith & Nephew plc and compare it with other stocks.